Home/Filings/4/0001144204-13-004105
4//SEC Filing

Buchbinder Aby 4

Accession 0001144204-13-004105

CIK 0000727510other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 6:14 PM ET

Size

6.2 KB

Accession

0001144204-13-004105

Insider Transaction Report

Form 4
Period: 2013-01-23
Buchbinder Aby
VP, Clinical Development
Transactions
  • Award

    Common Stock

    2013-01-23+3,74879,246 total
Footnotes (2)
  • [F1]This Form 4 is being filed to report the accelerated vesting of 3,748 restricted stock units (RSUs) that were originally granted to the Reporting Person on August 12, 2011. The August 12, 2011 grant consisted of 11,245 RSUs, which vest in full on August 12, 2014 if the Reporting Person remains employed by the Issuer on such date, provided that 50% of the RSUs are subject to accelerated vesting upon the achievement of certain performance milestones. Certain of the performance milestones applicable to the RSU grant were achieved, resulting in the accelerated vesting of 3,748 of the RSUs on January 23, 2013.
  • [F2]Because the RSUs granted to the Reporting Person on August 12, 2011 were previously included in the number of shares of common stock reported as beneficially owned by the Reporting Person, the accelerated vesting of 3,748 of the RSUs did not affect the number of shares reported as beneficially owned.

Issuer

ENZON PHARMACEUTICALS INC

CIK 0000727510

Entity typeother

Related Parties

1
  • filerCIK 0001526633

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 6:14 PM ET
Size
6.2 KB